Publications

5674 Results

Characterizing 18 years of death with dignity in Oregon

Authors
CD Blanke;M Leblanc;DL Hershman;L Ellis;F Meyskens
Journal / Conference
JAMA Oncology Oct 1;3(10):1403-1406; 2017 Apr 6 [Epub ahead of print]
Year
2017
Research Committee(s)
Cancer Care Delivery
PMID
PMID28384683
PMC
PMC5824315

Words matter: restoring respect and dignity when referring to humans with cancer [Commentary]

Authors
LM Ellis;CD Blanke;EC Kohn
Journal / Conference
Cancer Jul 1;123(13):2390-2391; 2017 Feb 9 [Epub ahead of print]
Year
2017
Research Committee(s)
Cancer Care Delivery
PMID
PMID28182266

Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru

Authors
K Boehnke;M Valdivieso;A Bussalleu;R Sexton;K Thompson;S Osorio;I Novoa Reyes;J Crowley;LH Baker;C Xi
Journal / Conference
Infection and Drug Resistance Mar 10;10:85-90
Year
2017
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID28331349
PMC
PMC5354526
Study Number(s)
S1119

Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial

Authors
D Winchester;C Till;P Goodman;C Tangen;R Santella;T Johnson-Pais;R Leach;J Xu;SL Zheng;IM Thompson;MS Lucia;SM Lippman;HL Parnes;WB Isaacs;AM De Marzo;CG Drake;EA Platz
Journal / Conference
Prostate Jun;77(8):908-919
Year
2017
Research Committee(s)
Cancer Control
PMID
PMID28317149
PMC
PMC5400704
Study Number(s)
SWOG-9217

The effect of positive SWOG treatment trials on survival of patients with cancer in the US population

Authors
JM Unger;M Leblanc;CD Blanke
Journal / Conference
JAMA Oncology Oct 1;3(10):1345-1351
Year
2017
Research Committee(s)
Breast, Cancer Care Delivery, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lung, Lymphoma, Multiple sites, and Myeloma
PMID
PMID28586789; PMC5710507
Study Number(s)
S0226, SWOG-7436, SWOG-7704/05, SWOG-7817, SWOG-8494 (INT-0036), SWOG-8501 (INT-0051), SWOG-8591(NCI Intergroup #0035), SWOG-8624, SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891), SWOG-8736 (INT-0093), SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12), SWOG-8814, SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817), SWOG-8897, SWOG-8949, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9126, SWOG-9210, SWOG-9308, S9916

A Stakeholder-Informed Randomized, Controlled Comparative Effectiveness Study of an Order Prescribing Intervention to Improve Colony Stimulating Factor use for Cancer Patients Receiving Myelosuppressive Chemotherapy: The TrACER Study

Authors
A Bansal;SD Sullivan;D Hershman;G Lyman;W Barlow;JS McCune;SD Ramsey
Journal / Conference
Journal of Comparative Effectiveness Research Jul;6(5):461-470. Epub 2017 Jul 7
Year
2017
Research Committee(s)
Cancer Care Delivery
PMID
PMID28686055
PMC
PMC5827800
Study Number(s)
S1415CD

Bacillus Calmette-Gue'rin manufacturing and SWOG S1602 Intergroup clinical trial [editorial]

Authors
JJ Meeks;SP Lerner;RS Svatek
Journal / Conference
Journal of Urology Mar;197(3 Pt 1):538-540; Epub 2016 Dec 16
Year
2017
Research Committee(s)
Genitourinary
PMID
PMID27992750
PMC
PMC n/a - editorial
Study Number(s)
S1602

Impact of DNA repair deficiency signature on outcomes in triple negative breast cancer (TNBC) patients treated with AC chemotherapy (SWOG S9313)

Authors
P Sharma;W Barlow;A Godwin;L Knight;SM Walker;RD Kennedy;S Badve;Y Gokmen-Polar;H Pathad;S Isakova;H Linden;D Tripathy;G Hortobagyi;D Hayes
Journal / Conference
J Clin Oncol 35, 2017 (suppl; abstr 529); American Society of Clinical Oncology (ASCO) Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
Year
2017
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

SWOG S0221 Updated: Comparison of two schedules of paclitaxel as adjuvant therapy for breast cancer

Authors
GT Budd;W Barlow;HCF Moore;T Hobday;JA Stewart;C Isaacs;M Salim;JK Cho;K Rinn;KS Albain;HK Chew;GV Burton;TD Moore;G Srkalovic;BA McGregor;LE Flaherty;RB Livingston;JR Gralow;G Hortobagyi
Journal / Conference
J Clin Oncol 35, 2017 (suppl; abstr 521); American Society of Clinical Oncology (ASCO) Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
Year
2017
Research Committee(s)
Breast
Study Number(s)
S0221

Effects of neoadjuvant chemotherapy (NAC) on tumor infiltrating lymphocytes (TIL) and PD-L1 expression in the SWOG S0800 clinical trial

Authors
V Pelekanou;W Barlow;M-C vonWahlde;B Wasserman;YC Lo;DF Hayes;G Hortobagyi;J Gralow;D Tripathy;RB Livingston;ZA Nahleh;DL Rimm
Journal / Conference
J Clin Oncol 35, 2017 (suppl; abstr 519); American Society of Clinical Oncology (ASCO) Annual Meeting (June 2-6, 2017, Chicago, IL), poster discussion
Year
2017
Research Committee(s)
Breast
Study Number(s)
S0800